Glabridin in Skincare Formulations: Licorice Extract’s Most Potent Brightening Flavonoid

By Melasyl Skin Tech Lab | Formula Science Series | July 2, 2026

Among the dozens of botanical extracts marketed for skin brightening, licorice (Glycyrrhiza glabra) root stands apart. Its hydrophobic fraction contains glabridin — a prenylated isoflavonoid that constitutes only 0.1–0.4% of root dry weight yet accounts for the majority of licorice extract’s depigmenting activity. For formulators seeking a natural, high-potency tyrosinase inhibitor that also delivers antioxidant and anti-inflammatory benefits, understanding glabridin’s formulation science is essential.

What Is Glabridin? Chemistry and Source

Glabridin (CAS 59870-68-7, molecular formula C₂₀H₂₀O₄, MW 324.37) is an isoflavan — a subclass of flavonoids characterized by a reduced heterocyclic C-ring. Its structure features two phenolic hydroxyl groups on the B-ring (positions 2′ and 4′), which are critical to its antioxidant and enzyme-inhibitory activities.

Dual Mechanism of Action: More Than Just a Tyrosinase Inhibitor

Glabridin’s skin brightening efficacy arises from two complementary mechanisms operating simultaneously — a rare feature among botanical actives.

Mechanism 1: Tyrosinase Inhibition

Glabridin is a non-competitive inhibitor of tyrosinase (Chen et al., 2016, Spectrochimica Acta Part A). It binds at a site distinct from the enzyme’s catalytic pocket, inducing a conformational change that reduces catalytic efficiency regardless of tyrosine or L-DOPA concentration. Fluorescence quenching and molecular docking studies confirm that glabridin interacts with tyrosinase primarily through hydrophobic forces and hydrogen bonding, with a binding constant K_a in the range of 10⁴–10⁵ M⁻¹.

The IC₅₀ for mushroom tyrosinase inhibition is reported at approximately 3.5 μM, making glabridin roughly 5–10× more potent than kojic acid (IC₅₀ ~17–50 μM depending on assay conditions) and comparable to some synthetic resorcinol derivatives — but without the regulatory baggage.

Mechanism 2: Downstream Pathway Suppression — PKA/MITF Signaling

More recent research (Pan et al., 2023, Food Science and Human Wellness) reveals that glabridin also acts upstream of tyrosinase by suppressing the PKA/MITF signaling axis:

1. Glabridin reduces cAMP-dependent PKA activation, thereby limiting CREB phosphorylation
2. Reduced CREB activity downregulates MITF (microphthalmia-associated transcription factor) transcription
3. Lower MITF means reduced expression of all three melanogenic enzymes: tyrosinase, TYRP1, and TYRP2
4. Additionally, glabridin was found to modulate the MAPK/ERK pathway, promoting MITF phosphorylation and degradation

This dual targeting — direct enzymatic inhibition plus transcriptional downregulation — makes glabridin one of the few natural compounds that address melanogenesis at both the catalytic and genetic levels.

Clinical and In Vivo Evidence

Yokota et al. (1998) first demonstrated that 0.5% glabridin applied topically inhibited UVB-induced pigmentation in guinea pig skin by approximately 80% compared to vehicle control. The effect was visible within 2 weeks of daily application.

A more recent study (Chiji et al., 2021, J. Microbiol. Biotechnol.) evaluated glabridin liposomes in a UVB-induced erythema model, showing significant suppression of inflammatory cytokines (IL-1β, TNF-α, PGE₂) alongside melanin reduction. This anti-inflammatory activity is particularly relevant for post-inflammatory hyperpigmentation (PIH), which disproportionately affects Southeast Asian skin (Fitzpatrick types III–V).

Formulation Challenges and Solutions

Challenge 1: Poor Aqueous Solubility

With water solubility below 1 µg/mL, glabridin cannot be dissolved directly in aqueous phases. Formulators have several options:

Challenge 2: pH Stability

Glabridin is most stable at pH 4.0–6.5. At pH >7.0, the phenolic hydroxyl groups undergo deprotonation, leading to oxidative degradation and color shift (yellow → brown). Formulations should be buffered to pH 5.0–5.5 for optimal stability.

Challenge 3: Photostability

Like many flavonoids, glabridin is UV-sensitive. It undergoes photodegradation when exposed to direct sunlight. Packaging in opaque or UV-coated containers is strongly recommended. Adding 0.05–0.1% EDTA as a metal chelator further improves oxidative stability.

Challenge 4: Color and Sensory

At concentrations above 0.3%, glabridin can impart a pale yellow tint to formulations. This is generally acceptable in creams and serums but may be undesirable in clear gels or “water-white” products. The HP-β-cyclodextrin complex approach can reduce visible color.

Recommended Usage Concentrations by Product Type

Synergy and Incompatibility

Effective Combinations

Ingredients to Avoid

• Strong oxidizing agents (concentrated benzoyl peroxide, hydrogen peroxide) — will directly oxidize glabridin’s phenolic groups
• High-pH formulations (>7.5) — cause deprotonation and accelerated degradation
• Strong reducing agents at high concentrations — may reduce glabridin’s activity through redox interaction
• Iron/copper-containing ingredients — catalyze Fenton-type oxidation of phenolic flavonoids

Starter Formula: 0.2% Glabridin Brightening Serum

Procedure:

1. Combine Phase A in main vessel, disperse xanthan gum with high-shear mixing until fully hydrated
2. Heat Phase A to 40–45°C
3. In separate vessel, pre-dissolve glabridin in butylene glycol (Phase B) with stirring until clear yellow solution forms (5–10 min)
4. Add Phase B to Phase A with moderate stirring
5. Add Phase C (niacinamide) with stirring until dissolved
6. Cool to <35°C, add Phase D
7. Adjust to pH 5.2 ± 0.2 with Phase E
8. Package in airless pump bottle, protect from light

ASEAN Regulatory and Market Considerations

• Glycyrrhiza glabra root extract is listed in the ASEAN Cosmetic Directive (ACD) Annex of permitted ingredients with no specific concentration restriction
• Glabridin as a purified isolate falls under general cosmetic ingredient safety assessment — a CPSR (Cosmetic Product Safety Report) should document purity and toxicological profile
• In Indonesia (BPOM), products containing concentrated licorice extract may require additional documentation if marketed with medicinal claims
• For Halal certification (critical for Malaysia/Indonesia markets): verify that extraction solvents (ethanol, methanol) are fully removed or that halal-compliant extraction (glycerin, propylene glycol) is used
• The “natural” positioning of glabridin aligns well with Southeast Asian consumer preference for botanical brightening ingredients

Comparison: Glabridin vs. Other Botanical Brighteners

Key Takeaways for Formulators

1. Dual-pathway action — glabridin uniquely combines direct tyrosinase inhibition with MITF transcriptional downregulation, making it more comprehensive than single-target botanical actives
2. Solubilization is non-negotiable — pre-dissolve in glycols, incorporate into oil phase, or use cyclodextrin complexation; never add glabridin powder directly to water
3. Optimal pH 5.0–5.5 — buffering is critical for both stability and skin compatibility
4. Effective at low concentrations — 0.1–0.3% net glabridin is sufficient; higher concentrations increase cost without proportional benefit
5. Truly natural with strong evidence base — one of the few botanical brighteners with multiple peer-reviewed mechanism-of-action studies and in vivo efficacy data
6. PIH management advantage — anti-inflammatory + anti-melanogenic dual action makes glabridin particularly suited for Southeast Asian skin types (III–V) prone to post-inflammatory hyperpigmentation

References

1. Chen, J., Yu, X., & Huang, Y. (2016). Inhibitory mechanisms of glabridin on tyrosinase. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 168, 111–117.
2. Pan, C.X., et al. (2023). The mechanisms of melanogenesis inhibition by glabridin: molecular docking, PKA/MITF and MAPK/MITF pathways. Food Science and Human Wellness, 12, 212–222.
3. Yokota, T., Nishio, H., Kubota, Y., & Mizoguchi, M. (1998). The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Research, 11(6), 355–361.
4. Wei, Y., Zhang, J., Zhou, Y., Bei, W., Li, Y., Yuan, Q., & Liang, H. (2017). Characterization of glabridin/hydroxypropyl-β-cyclodextrin inclusion complex with robust solubility and enhanced bioactivity. Carbohydrate Polymers, 159, 152–160.
5. Chiji, H., et al. (2021). Glabridin liposome ameliorating UVB-induced erythema and leathery skin by suppressing inflammatory cytokine production. Journal of Microbiology and Biotechnology, 31(4), 630–636.
6. Simmler, C., Pauli, G.F., & Chen, S.N. (2013). Phytochemistry and biological properties of glabridin. Fitoterapia, 90, 160–184.
7. Woolery-Lloyd, H., & Kammer, J.N. (2011). Treatment of hyperpigmentation. Seminars in Cutaneous Medicine and Surgery, 30(3), 171–175.
8. ASEAN Cosmetic Directive — Annexes (Latest Revision).

Melasyl Skin Tech Lab — Evidence-driven formulation science for skin brightening products. This article is part of our ongoing Formula Science series.